Healthcare - Biotechnology - NASDAQ - US
$ 51.8
-4.22 %
$ 2.23 B
Market Cap
-18.57
P/E
Price Target
Average
40.15%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
45.65%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Soleno Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for SLNO of $72.6 , with forecasts ranging from a low of $59 to a high of $93 .
SLNO Lowest Price Target
Wall Street Target
59 USD
13.90%
SLNO Average Price Target
Wall Street Target
72.6 USD
40.15%
SLNO Highest Price Target
Wall Street Target
93 USD
79.54%
REVENUE FORECAST
Revenue Forecast Chart SLNO
EBIT FORECAST
EBIT Forecast Chart SLNO
NET INCOME FORECAST
Net Income Chart SLNO